Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties
Open Access
- 15 November 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (10), 3710-3718
- https://doi.org/10.1182/blood-2002-04-1015
Abstract
MLL (mixed lineage leukemia; alsoALL-1 or HRX) is a proto-oncogene that is mutated in a variety of acute leukemias. Its product is normally required for the maintenance of Hox gene expression during embryogenesis and hematopoiesis through molecular mechanisms that remain poorly defined. Here we demonstrate that MLL (mixed lineage leukemia) is proteolytically processed into 2 fragments (MLLN and MLLC) that display opposite transcriptional properties and form an intramolecular MLL complex in vivo. Proteolytic cleavage occurs at 2 amino acids (D2666 and D2718) within a consensus processing sequence (QXD/GZDD, where X is a hydrophobic amino acid and Z is an alanine or a valine) that is conserved in TRX, the Drosophila homolog of MLL, and in the MLL-related protein MLL2, suggesting that processing is important for MLL function. Processed MLLN and MLLC associate with each other via N-terminal (1253-2254 amino acids) and C-terminal (3602-3742 amino acids) intramolecular interaction domains. MLL processing occurs rapidly within a few hours after translation and is followed by the phosphorylation of MLLC. MLLNdisplays transcriptional repression activity, whereas MLLChas strong transcriptional activation properties. Leukemia-associated MLL fusion proteins lack the MLL processing sites, do not undergo cleavage, and are unable to interact with MLLC. These observations suggest that posttranslational modifications of MLL may participate in regulating its activity as a transcription factor and that this aspect of its function is perturbed by leukemogenic fusions.This publication has 42 references indexed in Scilit:
- A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELLBlood, 2000
- Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in miceProceedings of the National Academy of Sciences of the United States of America, 2000
- Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemiaThe EMBO Journal, 2000
- Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ geneThe EMBO Journal, 2000
- MLL rearrangements in haematological malignancies: lessons from clinical and biological studiesBritish Journal of Haematology, 1999
- The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesisThe EMBO Journal, 1999
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996
- The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 geneCell, 1992
- Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemiasCell, 1992
- Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.Proceedings of the National Academy of Sciences of the United States of America, 1991